Ken Griffin Ishares Biotechnology ETF Call Options Transaction History

Citadel Advisors LLC

$505 Billion
Q3 2024

Call Options

9 transactions

Quarter	Operation	Price Per call	calls change	calls Held	SEC Form
Q3 2024 Nov 14, 2024	BUY	$135.09 - $149.47 $29.3 Million - $32.4 Million	217,000 Added 65.7%	547,300 $79.7 Million
Q2 2024 Aug 14, 2024	SELL	$124.64 - $139.96 $19.8 Million - $22.2 Million	-158,700 Reduced 32.45%	330,300 $45.3 Million
Q1 2024 May 15, 2024	SELL	$132.3 - $140.89 $10.5 Million - $11.2 Million	-79,600 Reduced 14.0%	489,000 $67.1 Million
Q4 2023 Feb 14, 2024	BUY	$112.41 - $137.03 $24.4 Million - $29.8 Million	217,500 Added 61.95%	568,600 $77.2 Million
Q3 2023 Nov 14, 2023	SELL	$122.27 - $131.47 $1.04 Million - $1.12 Million	-8,500 Reduced 2.36%	351,100 $42.9 Million
Q2 2023 Aug 14, 2023	SELL	$125.53 - $133.58 $25.1 Million - $26.7 Million	-200,100 Reduced 35.75%	359,600 $45.7 Million
Q1 2023 May 15, 2023	SELL	$121.97 - $137.23 $22.8 Million - $25.6 Million	-186,900 Reduced 25.03%	559,700 $72.3 Million
Q4 2022 Feb 14, 2023	BUY	$117.58 - $138.43 $21.3 Million - $25.1 Million	181,500 Added 32.12%	746,600 $98 Million
Q3 2022 Nov 14, 2022	BUY	$113.42 - $134.82 $20.1 Million - $23.9 Million	177,100 Added 45.64%	565,100 $66.1 Million

Others Institutions Holding IBB

# of Institutions

1,010

Shares Held

33.6M

Call Options Held

4M

Put Options Held

6.48M

About ISHARES BIOTECHNOLOGY ETF

Ticker IBB
Sector ETFs
Industry ETFs

Track Ken Griffin's Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Citadel Advisors LLC, based on Form 13F filings with the SEC.

News

Stay updated on Citadel Advisors LLC and Ken Griffin with notifications on news.